Literature DB >> 16946352

Spironolactone and risk of upper gastrointestinal events: association is unproved.

Muhammad F Dawwas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16946352      PMCID： PMC1557942          DOI： 10.1136/bmj.333.7566.501

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Helicobacter pylori infection.

Authors:  Sebastian Suerbaum; Pierre Michetti
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

2.  Peptic ulcer disease in patients with chronic liver disease: looking beyond bugs and drugs.

Authors:  Richard J Saad; William D Chey
Journal:  Gastrointest Endosc       Date:  2005-09       Impact factor: 9.427

3.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

4.  The diagnosis of heart failure in general practice: implications for the UK National Service Framework.

Authors:  Nigel Sparrow; David Adlam; Alan Cowley; John R Hampton
Journal:  Eur J Heart Fail       Date:  2003-06       Impact factor: 15.534

5.  Spironolactone and risk of upper gastrointestinal events: population based case-control study.

Authors:  Katia Verhamme; Georgio Mosis; Jeanne Dieleman; Bruno Stricker; Miriam Sturkenboom
Journal:  BMJ       Date:  2006-07-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.